Ginkgo biloba has been studied as a natural ingredient that improves male sexual function through effects on vascular activity. The leaves of Ginkgo biloba contain flavonoids, terpenoids, and other compounds that have been investigated for their antioxidant and vascular effects. These properties have led researchers to examine whether standardized Ginkgo biloba extracts could have applications in sexual health, including erectile function.

Introduction to the Clinical Studies of Ginkgo Biloba

The clinical evidence for Ginkgo biloba and male sexual function remains limited compared with evidence for established erectile dysfunction treatments. Research has included studies of sexual dysfunction in both men and women, but many trials were not designed specifically to evaluate erectile dysfunction in otherwise healthy men. A 2021 systematic review identified five randomized controlled trials involving 475 participants that examined Ginkgo biloba and sexual function, with findings that varied according to the population and cause of dysfunction.

Some clinical research has examined Ginkgo biloba as part of a combination treatment for men with erectile dysfunction and type 2 diabetes. One trial included 123 men and evaluated a nutraceutical containing Ginkgo biloba together with alpha-lipoic acid and Vitis vinifera, with some treatment groups also receiving avanafil.

What Current Evidence Shows

Existing studies provide a scientific basis for further investigation but do not establish Ginkgo biloba as a proven treatment for erectile dysfunction. Researchers have proposed that its vascular and antioxidant properties may be relevant to erectile physiology, but direct clinical evidence remains smaller and less consistent than evidence for conventional therapies.

Overall, Ginkgo biloba for erectile dysfunction remains an area of limited clinical research that requires better-designed trials with standardized extracts and clearly defined erectile-function outcomes. Current findings are useful for understanding potential mechanisms, but they should not be interpreted as proof of treatment effectiveness.

Ginkgo biloba has been investigated for sexual function because of its potential vascular and antioxidant effects, but direct evidence for erectile dysfunction remains limited, and combination studies cannot determine its independent effects.

Ginkgo Biloba: Mechanism of Action and Claimed Benefits

How Ginkgo Biloba May Affect Erectile Function

Ginkgo biloba is mainly studied for erectile function because its bioactive compounds may affect vascular function, oxidative stress, and blood circulation. Ginkgo leaves contain flavonoid glycosides and terpene lactones, including ginkgolides and bilobalide. These compounds have been investigated for effects on blood vessels, platelet activity, antioxidant defenses, and cellular signaling.

Normal erectile function depends on adequate blood flow through the penile arteries and relaxation of smooth muscle within erectile tissue. Sexual stimulation activates nitric oxide signaling, which increases cyclic guanosine monophosphate (cGMP) and promotes smooth-muscle relaxation. This process allows increased arterial inflow and expansion of the corpora cavernosa. Impairment of vascular function can interfere with this process and contribute to erectile dysfunction.

Proposed Mechanisms

Researchers have proposed several mechanisms through which Ginkgo biloba could potentially influence erectile function. These mechanisms include:

• Supporting endothelial function and vascular relaxation.
• Increasing peripheral blood flow through effects on vascular tone.
• Providing antioxidant activity that may help limit oxidative stress.
• Affecting platelet aggregation and blood-flow characteristics.
• Potentially influencing nitric oxide-related signaling.
• Supporting vascular function in conditions associated with impaired circulation.

The vascular effects of Ginkgo biloba provide the main biological rationale for studying it in erectile dysfunction. Oxidative stress and endothelial dysfunction are associated with reduced nitric oxide availability, which can impair the vascular response required for an erection. Ginkgo’s antioxidant and vascular effects have therefore attracted interest as possible contributors to improved erectile responses.

Claimed Sexual Health Benefits

Claims about Ginkgo biloba for erectile dysfunction generally focus on improved penile circulation and sexual response rather than direct hormonal effects. Some research has also examined its potential influence on sexual desire, arousal, and other aspects of sexual function, although these outcomes are not equivalent to demonstrating an improvement in erectile dysfunction.

The proposed mechanisms do not establish that Ginkgo biloba produces a clinically meaningful improvement in erections. Laboratory findings and physiological mechanisms can explain why an ingredient might be studied, but controlled clinical trials are required to determine whether these effects translate into measurable improvements in patients.

Ginkgo biloba may affect pathways relevant to erectile function through vascular, antioxidant, and nitric oxide-related mechanisms, but these proposed effects require clinical confirmation.

Why Ginkgo Biloba Is Studied for Erectile Dysfunction Treatment

Interest in Vascular Function

Ginkgo biloba has been studied for erectile dysfunction because penile erection depends on healthy blood vessels and adequate blood flow. The erectile response requires relaxation of vascular smooth muscle, increased arterial inflow, and effective trapping of blood within erectile tissue. Conditions that impair endothelial function or reduce vascular responsiveness can interfere with this process.

Researchers have therefore considered whether the vascular effects attributed to Ginkgo biloba could also influence erectile function. Ginkgo leaf extracts have been investigated for their effects on circulation, vascular tone, oxidative stress, and platelet activity. These effects provide a biological rationale for studying the ingredient in conditions where impaired vascular function may contribute to sexual difficulties.

Erectile Dysfunction and Vascular Health

Erectile dysfunction is often associated with cardiovascular and metabolic factors that can also affect vascular function throughout the body. Hypertension, diabetes, atherosclerosis, smoking, obesity, and abnormal lipid levels can contribute to endothelial dysfunction and reduced blood flow. Because these factors can affect both cardiovascular and erectile function, researchers have investigated natural compounds with potential vascular activity.

Ginkgo biloba has attracted particular interest because its constituents have antioxidant and vascular properties that may be relevant to endothelial function. Oxidative stress can reduce the availability of nitric oxide, an important signaling molecule involved in the relaxation of penile smooth muscle. Researchers have therefore explored whether Ginkgo’s effects on oxidative processes and vascular signaling could have secondary effects on erectile responses.

Research Questions

Clinical studies of Ginkgo biloba for erectile dysfunction have generally focused on whether these proposed physiological effects produce measurable improvements in sexual function. Researchers may examine outcomes such as erection quality, ability to achieve or maintain an erection, sexual satisfaction, and standardized erectile-function questionnaire scores.

The ingredient has also been studied in populations where erectile dysfunction may have a vascular or medication-related component. Earlier research included men with erectile difficulties associated with antidepressant treatment, while more recent research has examined Ginkgo-containing formulations in men with metabolic conditions.

These research settings help explain why Ginkgo biloba continues to attract scientific interest despite limited direct evidence. The primary rationale comes from its potential effects on vascular and oxidative pathways rather than from established evidence that it directly treats the underlying causes of erectile dysfunction.

Ginkgo biloba has been studied for erectile dysfunction mainly because its potential vascular and antioxidant effects could influence biological processes involved in penile erection, but clinical research is still limited.

How Clinical Studies of Ginkgo Biloba Are Designed

Study Designs

Clinical studies of Ginkgo biloba for erectile dysfunction use different designs to determine whether supplementation is associated with measurable changes in sexual function. Randomized controlled trials provide stronger evidence because researchers can compare participants receiving Ginkgo biloba with those receiving placebo or another intervention. Some studies have also evaluated Ginkgo biloba as part of a combination product, which makes it difficult to determine the ingredient’s individual contribution.

Researchers typically select participants based on defined sexual-function criteria and may exclude factors that could strongly affect erectile function. Study populations can include men with erectile dysfunction related to medical conditions, medication use, or other health factors. The duration of treatment can vary, and studies may use standardized Ginkgo biloba extracts at specific doses.

Measuring Erectile Function

Researchers use standardized clinical measures to determine whether participants experience changes in erectile function during or after treatment. Common outcomes can include:

• International Index of Erectile Function (IIEF) scores.
• Ability to achieve or maintain an erection.
• Erectile rigidity.
• Sexual desire and satisfaction.
• Frequency of successful sexual activity.
• Patient-reported changes in overall sexual function.
• Adverse events and treatment tolerability.

The IIEF is particularly useful because it provides a standardized method for assessing several domains of male sexual function. Its erectile-function domain focuses on the ability to achieve and maintain erections and can help researchers compare changes between treatment and control groups.

Interpreting Study Outcomes

A well-designed trial compares changes from baseline between groups rather than relying only on participants’ reports of improvement. Researchers may calculate changes in questionnaire scores and assess whether differences between groups reach statistical significance. Clinical relevance also matters because a statistically detectable change may not represent a meaningful improvement for patients.

Studies that combine Ginkgo biloba with other ingredients require additional caution when interpreting their findings. If participants receive several active compounds simultaneously, researchers cannot reliably attribute an observed improvement to Ginkgo biloba alone.

Study duration, sample size, extract standardization, dosage, and participant characteristics can also influence the results. These factors should be considered when comparing findings from different clinical trials.

Clinical studies of Ginkgo biloba for erectile dysfunction generally assess changes in standardized sexual-function measures, with randomized controlled trials offering stronger evidence and combination products making individual effects harder to determine.

Clinical Studies of Ginkgo Biloba for Erectile Dysfunction

Clinical research on Ginkgo biloba and sexual function includes several controlled trials, but only a small number of studies have directly examined men with erectile dysfunction. A 2021 systematic review identified five randomized controlled trials involving 475 participants and concluded that evidence for Ginkgo biloba and sexual function was confirmed, with the best positive findings mainly reported in men with antidepressant-associated sexual dysfunction. The available studies are therefore useful for assessing possible effects on sexual function, but they should not be interpreted as establishing Ginkgo biloba as the only treatment for male erectile dysfunction.

Ginkgo Biloba for Antidepressant-Induced Sexual Dysfunction — 1998

Cohen and Bartlik conducted an open clinical trial involving 63 people with sexual dysfunction associated mainly with antidepressant use. Participants received Ginkgo biloba extract at doses ranging from 60 mg daily to 120 mg twice daily, with an average dose of approximately 209 mg per day. The authors reported improvement in several aspects of sexual response, including desire, excitement, erection or lubrication, orgasm, and resolution. Among the participants, 30 were men, and the reported response rate was 76% in men.

Measured outcome: Changes in the four phases of sexual response, including erection in male participants.

Link: Study on PubMed

Ginkgo Biloba for Antidepressant-Induced Sexual Dysfunction — 2002

Kang and colleagues conducted a randomized, double-blind, placebo-controlled trial involving 37 participants with antidepressant-induced sexual dysfunction. Nineteen participants received Ginkgo biloba and 18 received placebo for two months. The researchers found no statistically significant difference between Ginkgo and placebo at weeks 2, 4, or 8. Both groups showed some improvement from baseline, suggesting that placebo effects may have influenced the results.

Measured outcome: Changes in sexual-function measures during eight weeks of treatment.

Link: Study on PubMed

Ginkgo Biloba for Antidepressant-Associated Sexual Dysfunction — 2004

Wheatley performed a triple-blind, randomized, placebo-controlled study of Ginkgo biloba in 24 people with sexual impairment caused by antidepressant medication. Participants received 240 mg of Ginkgo biloba daily, with treatment continuing for up to 12 weeks. The final efficacy analysis included 13 participants in the placebo group and 11 in the Ginkgo group. The study found no statistically significant difference between the groups, although individual participants in both groups reported substantial responses.

Measured outcome: A validated sex-specific questionnaire assessing sexual function, together with anxiety, depression, alertness, and memory assessments.

Link: Study on PubMed

Ginkgo-Containing Nutraceutical in Men With Diabetes and Erectile Dysfunction — 2022

A clinical trial involving 123 men with type 2 diabetes and erectile dysfunction evaluated a nutraceutical containing Ginkgo biloba, alpha-lipoic acid, and Vitis vinifera, with or without avanafil. After three months, the group receiving the nutraceutical plus avanafil had a higher International Index of Erectile Function score than the placebo, avanafil-alone, and nutraceutical-alone groups. The study therefore provides evidence relevant to Ginkgo-containing treatment for erectile dysfunction, but it cannot isolate the effect of Ginkgo biloba because the nutraceutical contained multiple active ingredients.

Measured outcome: International Index of Erectile Function score, fasting glucose, insulin resistance, inflammatory markers, and metalloproteinases.

Link: Study on PubMed

Summary of Clinical Evidence

The clinical evidence for Ginkgo biloba in erectile dysfunction remains mixed but sufficient to confirm independent treatment effectiveness. An early uncontrolled study reported improvements in sexual response, while later placebo-controlled trials of antidepressant-associated sexual dysfunction did demonstrate significant benefits over placebo. Research in men has produced some positive findings for sexual desire or short-term physiological arousal, but these results do not directly establish efficacy for male erectile dysfunction. The 2022 study provides more direct evidence in men with diabetes and erectile dysfunction, but the use of a combination product prevents attribution of the outcome to Ginkgo biloba alone.

Overall, Ginkgo biloba remains a subject of clinical research for sexual function, with potential vascular effects providing a rationale for further investigation and sometimes even direct evidence for erectile dysfunction.

Limitations of Existing Research on Ginkgo Biloba for Erectile Dysfunction

Limited Direct Evidence

The main limitation of research on Ginkgo biloba for erectile dysfunction is the small amount of clinical evidence that directly evaluates men with this condition. Several published studies have investigated sexual dysfunction more broadly or focused on antidepressant-associated sexual problems rather than erectile dysfunction caused by vascular, metabolic, or other common factors.

Many studies also include relatively small numbers of participants, which limits the ability to determine whether the observed findings apply to larger and more diverse populations. Small trials can produce uncertain estimates of treatment effects and may not adequately identify less common adverse effects.

Study Design and Product Differences

Differences in study design make it difficult to compare results across clinical trials of Ginkgo biloba. Researchers have used different doses, treatment durations, participant populations, outcome measures, and study protocols. These differences can contribute to inconsistent findings.

The composition of Ginkgo products is another important limitation because extracts can differ in their concentrations of active constituents. Standardization of the extract is important when comparing clinical results, but not all studies use identical preparations or provide the same level of information about product composition.

Combination Treatments

Some research involving erectile dysfunction has evaluated Ginkgo biloba as part of a combination product containing other potentially active ingredients. For example, a study in men with type 2 diabetes and erectile dysfunction examined a nutraceutical containing Ginkgo biloba, alpha-lipoic acid, and grape-seed-derived compounds. A positive result from such a product cannot establish that Ginkgo biloba alone produced the observed effect.

Outcome and Follow-Up Limitations

Studies also vary in how they measure sexual function, which can make direct comparisons difficult. Standardized instruments such as the International Index of Erectile Function provide useful quantitative data, while subjective reports may be more sensitive to expectations and placebo effects.

Long-term evidence remains limited, particularly regarding sustained improvements in erectile function and long-term safety. More research with larger populations, standardized extracts, appropriate placebo controls, and clearly defined erectile-function outcomes would help clarify the potential role of Ginkgo biloba.

Existing research is limited by small samples, different Ginkgo preparations, varied study designs, combination treatments, and limited long-term data, leaving uncertainty about the independent clinical effectiveness of Ginkgo biloba for erectile dysfunction.

Summary of Clinical Studies of Ginkgo Biloba for Erectile Dysfunction

Clinical studies of Ginkgo biloba provide some evidence of possible effects on sexual function, but the evidence specifically supporting its use for erectile dysfunction remains limited. Research has examined several populations, including men and women with sexual dysfunction associated with antidepressants, postmenopausal women with reduced sexual desire, and men with erectile dysfunction associated with type 2 diabetes.

Findings From Clinical Research

Early research reported improvements in several aspects of sexual function among people taking Ginkgo biloba, including erectile function in some male participants. However, the early study was open-label and did not include a placebo control, so its findings cannot establish that Ginkgo caused the reported improvements.

Studies involving antidepressant-associated sexual dysfunction managed to demonstrate a statistically significant advantage for Ginkgo biloba compared with placebo.

Some research has reported improvements in specific aspects of sexual function rather than erectile function itself. Studies involving women have examined outcomes such as sexual desire, physiological arousal, and sexual satisfaction, with some positive findings. However, results from female populations cannot be directly applied to men with erectile dysfunction.

Evidence in Men With Erectile Dysfunction

A more recent clinical study evaluated a Ginkgo-containing nutraceutical in men with type 2 diabetes and erectile dysfunction. The formulation also contained alpha-lipoic acid and grape-derived compounds, and some participants received avanafil. Improvements in International Index of Erectile Function scores were reported in the combination-treatment group, but the study could not determine the independent contribution of Ginkgo biloba.

The available evidence therefore supports continued scientific interest rather than a definitive conclusion about treatment effectiveness. The proposed vascular and antioxidant mechanisms provide a biological basis for research, but clinical outcomes remain inconsistent and direct evidence is relatively scarce.

Overall Research Assessment

Future trials should use standardized Ginkgo extracts, adequate sample sizes, placebo controls, validated erectile-function measures, and sufficient treatment and follow-up periods. Studies should also evaluate Ginkgo biloba as a standalone intervention so researchers can separate its effects from those of other ingredients.

Clinical research suggests that Ginkgo biloba may influence certain aspects of sexual function, but current evidence does not establish consistent or independent effectiveness for erectile dysfunction. Larger, well-controlled trials are needed to determine its clinical value.